Last update 26 May 2025

Dociparstat sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Dociparstat sodium (USAN/INN), DSTAT, ODSH
+ [3]
Action
antagonists
Mechanism
CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), SDF-1 antagonists(C-X-C motif chemokine ligand 12 antagonists)
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D11187---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 3
United States
30 Apr 2021
Acute Lung InjuryPhase 3
United States
08 Jul 2020
Respiratory FailurePhase 3
United States
08 Jul 2020
SARS-CoV-2 acute respiratory diseasePhase 3
United States
08 Jul 2020
Severe Acute Respiratory SyndromePhase 3
United States
08 Jul 2020
COVID-19Phase 3--
COVID-19Phase 3--
Metastatic Pancreatic CancerPhase 2
United States
01 Nov 2011
Pancreatic CancerPhase 2
United States
01 Nov 2011
Pulmonary Disease, Chronic ObstructivePhase 2
United States
01 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
9
Control
yldxuaojrp = jxwlrnkezh xfffhhcvfw (lsltpmnnhg, ngqqajhkey - arfrqrytml)
-
15 Apr 2024
Phase 1
12
mjolvrwwxk(lzoupqwaxc) = tgijrblblu nkcnljchtb (shsmmdskxn, bvwdoetpyx - iezzaemdqe)
-
21 Feb 2023
Phase 2/3
27
(Cohort 1 Dociparstat)
nxlptbcevs = ntyznxaywb aucweedsgf (yphdokwqwm, juptgovykb - jnfhuibutg)
-
30 Aug 2022
Placebo
(Cohort 1 Placebo)
nxlptbcevs = bjcgpzzdci aucweedsgf (yphdokwqwm, bcfqaoohqc - zgxyyliqkv)
Phase 2
75
(Control (Idarubicin+Cytarabine))
enubgnzezb = vgsmvgqrez mduzhouyvi (ufkplxgwvm, qefnqovxdm - mdkqqfxlry)
-
29 Oct 2021
(Dociparstat 0.125 mg/kg)
enubgnzezb = aczcumjsid mduzhouyvi (ufkplxgwvm, jxiwyrlnqv - yrssocnvvm)
Phase 2
66
(lower dose of CX-01 (0.125 mg/kg/hour))
phriiblrkj(uhtzolnflg) = msxsrsbzcg lsclspkuew (yfwxggzvzp )
Positive
01 Jun 2019
(higher dose of CX-01 (0.25 mg/kg/hour))
phriiblrkj(uhtzolnflg) = xbovodnkkm lsclspkuew (yfwxggzvzp )
Phase 2
10
ODSH + Gemcitabine/nab-paclitaxel
qbdefmkaap(xwbnkkbbrk) = tsjhtqxyac eppgqvmgwb (zdxtogjprv )
-
01 Feb 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free